Low grade nasopharyngeal papillary adenocarcinoma case report from the Middle East

Authors

  • Suzan S. Mohammed Department of Otolaryngology, Hamad Medical Corporation, Doha, Qatar
  • Hassan H. Ahmad Department of Otolaryngology, Hamad Medical Corporation, Doha, Qatar
  • Adham A. Ammar Department of Laboratory, Hamad Medical Corporation Doha, Qatar
  • Waheed Rahman Department of Otolaryngology, Hamad Medical Corporation, Doha, Qatar

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20203581

Keywords:

Papillary adenocarcinoma, Nasopharyngeal, Carcinoma

Abstract

Nasopharyngeal papillary adenocarcinoma variety is extremely rare type of nasopharyngeal carcinoma. Limited number of cases reported in the literature, with most cases being reported from west and south Asia. We report the first case in English literature from the middle east and south Africa. A young gentleman diagnosed with low-grade nasopharyngeal papillary adenocarcinoma with positive cervical lymph node. He received a combined approach with endoscopic resection of the lesion and concomitant Left neck dissection followed by planned chemoradiotherapy. Through this case report, we would like to share our treatment approach and explore the optimum therapeutic strategies for primary nasopharyngeal papillary adenocarcinomas.

 

References

Petersson, F, Niedobitek MH, Goldsmith DB, Chan SH, Hildesheim A, Zou XN, S. L. Update from The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx. 1970.

Stelow EB, Wenig BM. Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx. Head Neck Pathol. 2017;11(1):16-22.

Thompson LD. Nasopharyngeal Papillary Adenocarcinoma. Ear, nose and Throat Journal. 2017;96(12):456-57.

Li M, Wei J, Yao X, Wang C. Clinicopathological Features of Low-Grade Thyroid-like Nasopharyngeal Papillary Adenocarcinoma. Cancer Res Treat. 2017;49(1):213-218.

Horino T, Ichii O, Ode HK, Matsumoto T, Shimamura Y, Inoue K, Terada Y. Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: A case report. Molecular and clinical oncology. 2016;5(6):693-96.

Yu MC, Yuan J. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12(6):421-429.

Wenig BM, Hyams VJ, Heffner DK. Nasopharyngeal papillary adenocarcinoma. A clinicopathologic study of a low-grade carcinoma. Am J Surg Pathol. 1988;12(12):946-953.

Thompson L. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J. 2006;85(2):74.

Wenig BM, Hyams VJ, Heffner DK. Nasopharyngeal papillary adenocarcinoma. A clinicopathologic study of a low-grade carcinoma. Am J Surg Pathol. 1988;12:946-953.

D'Cruz AK, Robinson MH, Biel MA. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck. 2004;26(3):232-240.

Lou PJ, Jager HR, Jones L, Theodossy T, Bown SG, Hopper C. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer. 2004;91(3):441-446.

Wang CP, Chang YL, Chen CT, Yang TH, Lou PJ. Photodynamic Therapy With Topical 5-aminolevulinic Acid as a Post-Operative Adjuvant Therapy for an Incompletely Resected Primary Nasopharyngeal Papillary Adenocarcinoma: A Case Report. Lasers Surg Med. 2006;38(5):435-8.

Wang X, Yan H, Luo Y, Fan T. Low-grade nasopharyngeal papillary adenocarcinoma: a case report and review of the literature. Onco Targets Ther. 2016;9:2955-9.

Downloads

Published

2020-08-25

Issue

Section

Case Reports